tirzepatide surpass 2 monotherapy in Chinese patients with early type diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO) Efficacy of tirzepatide 5, 10
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13




























